Effective and compliant computer system data management is critical to organizations in the pharmaceutical, biologics, vaccines, tobacco, animal health, medical device or other FDA-regulated industry. During the past 30 years, best practices have been developed to ensure computer systems used in these environments can be cost-effectively managed while meeting all aspects of FDA compliance. To take this a step further, we are now looking at ways to ensure the data that resides on these systems is also managed in a compliant manner and one that will provide the best results for operations at the lowest cost.
Join this session by expert speaker Carolyn Troiano, where she will discuss how to govern data, using a system of decision rights and accountabilities for information-related processes, executed according to agreed-upon models which describe who can take what actions with what information, and when, under what circumstances, and, finally, using what methods.
Session Highlights:
Upon completion of this session, attendees will have an understanding of how to:
Tie data integrity management activities and investments to corporate drivers, strategies and compliance
Establish data governance program objectives, decision-making organizational structures and assigned roles and responsibilities that fit within the organizational culture to ensure data integrity is maintained throughout its life cycle
Understand the role of data owners vs. data stewards in establishing and maintaining data integrity
Understand the criticality of data identity, trust, security, integrity, accessibility, reliability and consistency
Design a framework that encompasses people, processes and technology to ensure that all data is established and maintained in a state of integrity and in compliance with FDA requirements
Understand the policies and procedures necessary to support the maintenance of data integrity within a structured framework
Learn about the important concepts related to creating, maintaining and managing data integrity through good data governance practices
Learn how to document Computer System Validation (CSV) efforts to meet FDA compliance
Learn the most common pitfalls and challenges encountered when preparing documentation for FDA review
Learn about the best practices for documenting CSV efforts in alignment with the System Development Life Cycle (SDLC) methodology and FDA compliance
Learn about 21 CFR Part 11, FDA’s guidance for electronic records and electronic signatures and what you need to do to remain compliant
Learn about FDA compliance and enforcement trends
Why You Should Attend:
After attending this webinars, you will understand the latest guidance and clarification issued by FDA on maintaining data integrity throughout the data life cycle. This is a quality control discipline necessary for assessing, managing, using, improving, monitoring, maintaining, and protecting organizational data that is used to produce information leading to key decisions about products and regulatory matters.
Who Should Attend:
Information Technology Analysts
QC/QA Managers
QC/QA Analysts
Clinical Data Managers
Clinical Data Scientists
Analytical Chemists
Compliance Managers
Laboratory Managers
Automation Analysts
Manufacturing Managers
Manufacturing Supervisors
Supply Chain Specialists
Computer System Validation Specialists
GMP Training Specialists
Business Stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit
Consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance
Auditors engaged in the internal inspection of labeling records and practices
*You may ask your Question directly to our expert during the Q&A session.
** You can buy On-Demand and view it as per your convenience.
Carolyn Troiano
Carolyn Troiano has more than 35 years of experience in computer system validation in the pharmaceutical, medical device, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on FDA compliance, computer system validation and large-scale IT system implementation projects. Carolyn participated in the Industry/FDA partnership that developed 21 CFR Part 11, the FDA’s guidance on electronic records and electronic signatures (ER/ES).